Skip to main content
Top
Published in: BMC Infectious Diseases 1/2001

Open Access 01-12-2001 | Research article

Bacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort study

Authors: Bekele Afessa, Ian Morales, Bethany Weaver

Published in: BMC Infectious Diseases | Issue 1/2001

Login to get access

Abstract

Background

Bacterial infections complicate the course of patients with human immunodeficiency virus infection. The purpose of this study was to describe the bacterial pathogens causing blood stream infection, identify the risk factors for the development of blood stream infection and determine the impact of blood stream infection on the outcome of patients infected with human immunodeficiency virus.

Methods

The incidence, etiology, risk factors and outcome of bacterial blood stream infection were prospectively determined in 1,225 consecutive hospitalizations of adults with human immunodeficiency virus infection.

Results

Blood stream infection occurred in 88 hospitalizations (7%); 73 of 89 infections (82%) were community acquired. The most commonly isolated gram-positive organism was Streptococcus pneumoniae (21); gram-negative, Escherichia coli (14). Blood stream infection was detected in 8% of African Americans and 22% of Hispanics compared with 2% of whites (P = 0.0013). Patients with blood stream infection had higher white blood cell counts (median, 6.5 vs. 4.9 × 109/L; P = 0.0002) and mortality (18% vs. 4%; P < 0.0001) than patients without infection.

Conclusions

In patients with human immunodeficiency virus, blood stream infection is associated with an increased mortality rate. Recognition of the incidence, etiology, and risk factors of blood stream infection in patients with human immunodeficiency virus infection could lead to measures that reduce the increased mortality.
Literature
1.
go back to reference Whimbey E, Gold JW, Polsky B, Dryjanski J, Hawkins C, Blevins A, Brannon P, Kiehn TE, Brown AE, Armstrong D: Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986, 104: 511-514.CrossRefPubMed Whimbey E, Gold JW, Polsky B, Dryjanski J, Hawkins C, Blevins A, Brannon P, Kiehn TE, Brown AE, Armstrong D: Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986, 104: 511-514.CrossRefPubMed
2.
go back to reference Northfelt DW, Polsky B: Bacteremia in persons with HIV infection. AIDS Clin Rev. 1991, 59-79. Northfelt DW, Polsky B: Bacteremia in persons with HIV infection. AIDS Clin Rev. 1991, 59-79.
3.
4.
go back to reference Keiser P, Higgs E, Smith J: Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci. 1996, 312: 118-122. 10.1097/00000441-199609000-00004.CrossRefPubMed Keiser P, Higgs E, Smith J: Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci. 1996, 312: 118-122. 10.1097/00000441-199609000-00004.CrossRefPubMed
5.
go back to reference Moore RD, Keruly JC, Chaisson RE: Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med. 1995, 155: 1965-1970. 10.1001/archinte.155.18.1965.CrossRefPubMed Moore RD, Keruly JC, Chaisson RE: Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med. 1995, 155: 1965-1970. 10.1001/archinte.155.18.1965.CrossRefPubMed
6.
go back to reference Meyer CN, Skinhoj P, Prag J: Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis. 1994, 26: 635-642.CrossRefPubMed Meyer CN, Skinhoj P, Prag J: Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis. 1994, 26: 635-642.CrossRefPubMed
7.
go back to reference Stein M, O'Sullivan P, Wachtel T, Fisher A, Mikolich D, Sepe S, Fort G, Carpenter C, Skowron G, Mayer K: Causes of death in persons with human immunodeficiency virus infection. Am J Med. 1992, 93: 387-390.CrossRefPubMed Stein M, O'Sullivan P, Wachtel T, Fisher A, Mikolich D, Sepe S, Fort G, Carpenter C, Skowron G, Mayer K: Causes of death in persons with human immunodeficiency virus infection. Am J Med. 1992, 93: 387-390.CrossRefPubMed
8.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-829.CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med. 1985, 13: 818-829.CrossRefPubMed
9.
go back to reference Vugia DJ, Kiehlbauch JA, Yeboue K, N'Gbichi JM, Lacina D, Maran M, Gondo M, Kouadio K, Kadio A, Lucas SB, et al: Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, west Africa. J Infect Dis. 1993, 168: 564-570.CrossRefPubMed Vugia DJ, Kiehlbauch JA, Yeboue K, N'Gbichi JM, Lacina D, Maran M, Gondo M, Kouadio K, Kadio A, Lucas SB, et al: Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, west Africa. J Infect Dis. 1993, 168: 564-570.CrossRefPubMed
10.
go back to reference Frank U, Daschner FD, Schulgen G, Mills J: Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis. 1997, 25: 318-320.CrossRefPubMed Frank U, Daschner FD, Schulgen G, Mills J: Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis. 1997, 25: 318-320.CrossRefPubMed
11.
go back to reference Fichtenbaum CJ, Dunagan WC, Powderly WG: Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 8: 51-57.CrossRefPubMed Fichtenbaum CJ, Dunagan WC, Powderly WG: Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 8: 51-57.CrossRefPubMed
12.
go back to reference Krumholz HM, Sande MA, Lo B: Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med. 1989, 86: 776-779.CrossRefPubMed Krumholz HM, Sande MA, Lo B: Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med. 1989, 86: 776-779.CrossRefPubMed
13.
go back to reference Bonadio M, Gigli C, Maccanti O, Longo B, Smorfa A: Bloodstream infections in HIV-positive patients: a review of sixty-eight episodes. J Chemother. 1998, 10: 243-247.CrossRefPubMed Bonadio M, Gigli C, Maccanti O, Longo B, Smorfa A: Bloodstream infections in HIV-positive patients: a review of sixty-eight episodes. J Chemother. 1998, 10: 243-247.CrossRefPubMed
14.
go back to reference Tumbarello M, Tacconelli E, Donati KG, Citton R, Leone F, Spanu T, Cauda R: HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr. 2000, 23: 145-151.CrossRefPubMed Tumbarello M, Tacconelli E, Donati KG, Citton R, Leone F, Spanu T, Cauda R: HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr. 2000, 23: 145-151.CrossRefPubMed
15.
go back to reference Manfredi R, Nanetti A, Ferri M, Chiodo F: HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era (letter). AIDS. 1999, 13: 1274-1276. 10.1097/00002030-199907090-00019.CrossRefPubMed Manfredi R, Nanetti A, Ferri M, Chiodo F: HIV-associated non-mycobacterial sepsis-bacteraemia, before and during the highly active antiretroviral therapy era (letter). AIDS. 1999, 13: 1274-1276. 10.1097/00002030-199907090-00019.CrossRefPubMed
16.
go back to reference Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L: The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect. 1995, 31: 123-131.CrossRefPubMed Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L: The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect. 1995, 31: 123-131.CrossRefPubMed
17.
go back to reference Hickey MM, Shanson DC: Septicaemia in patients with and without AIDS at Westminster Hospital, London. J Infect. 1993, 27: 243-250.CrossRefPubMed Hickey MM, Shanson DC: Septicaemia in patients with and without AIDS at Westminster Hospital, London. J Infect. 1993, 27: 243-250.CrossRefPubMed
18.
go back to reference Mendelson MH, Gurtman A, Szabo S, Neibart E, Meyers BR, Policar M, Cheung TW, Lillienfeld D, Hammer G, Reddy S, et al: Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis. 1994, 18: 886-895.CrossRefPubMed Mendelson MH, Gurtman A, Szabo S, Neibart E, Meyers BR, Policar M, Cheung TW, Lillienfeld D, Hammer G, Reddy S, et al: Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis. 1994, 18: 886-895.CrossRefPubMed
19.
go back to reference Omenaca C, Turett G, Yarrish R, Astiz M, Lin R, Kislak JW, Cadden J: Bacteremia in HIV-infected patients: short-term predictors of mortality. J Acquir Immune Defic Syndr. 1999, 22: 155-160.CrossRefPubMed Omenaca C, Turett G, Yarrish R, Astiz M, Lin R, Kislak JW, Cadden J: Bacteremia in HIV-infected patients: short-term predictors of mortality. J Acquir Immune Defic Syndr. 1999, 22: 155-160.CrossRefPubMed
20.
go back to reference Edge MD, Rimland D: Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS. 1996, 10: 1635-1639.CrossRefPubMed Edge MD, Rimland D: Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS. 1996, 10: 1635-1639.CrossRefPubMed
21.
go back to reference Redd SC, Rutherford GW, Sande MA, Lifson AR, Hadley WK, Facklam RR, Spika JS: The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990, 162: 1012-1017.CrossRefPubMed Redd SC, Rutherford GW, Sande MA, Lifson AR, Hadley WK, Facklam RR, Spika JS: The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990, 162: 1012-1017.CrossRefPubMed
22.
go back to reference Meynard JL, Barbut F, Guiguet M, Batisse D, Lalande V, Lesage D, Guiard-Schmid JB, Petit JC, Frottier J, Meyohas MC: Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect. 1999, 38: 176-181.CrossRefPubMed Meynard JL, Barbut F, Guiguet M, Batisse D, Lalande V, Lesage D, Guiard-Schmid JB, Petit JC, Frottier J, Meyohas MC: Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect. 1999, 38: 176-181.CrossRefPubMed
23.
go back to reference Manfredi R, Nanetti A, Ferri M, Chiodo F: Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol. 2000, 16: 111-118. 10.1023/A:1007626410724.CrossRefPubMed Manfredi R, Nanetti A, Ferri M, Chiodo F: Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey. Eur J Epidemiol. 2000, 16: 111-118. 10.1023/A:1007626410724.CrossRefPubMed
24.
go back to reference Vidal F, Mensa J, Martinez JA, Almela M, Marco F, Gatell JM, Richart C, Soriano E, Jimenez de Anta MT: Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 1999, 18: 473-477. 10.1007/s100960050326.CrossRefPubMed Vidal F, Mensa J, Martinez JA, Almela M, Marco F, Gatell JM, Richart C, Soriano E, Jimenez de Anta MT: Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis. 1999, 18: 473-477. 10.1007/s100960050326.CrossRefPubMed
25.
go back to reference Afessa B, Green B: Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest. 2000, 117: 1017-1022. 10.1378/chest.117.4.1017.CrossRefPubMed Afessa B, Green B: Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest. 2000, 117: 1017-1022. 10.1378/chest.117.4.1017.CrossRefPubMed
26.
go back to reference Manfredi R, Costigliola P, Ricchi E, Chiodo F: Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Ter. 1993, 143: 279-290.PubMed Manfredi R, Costigliola P, Ricchi E, Chiodo F: Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Ter. 1993, 143: 279-290.PubMed
27.
go back to reference Tumbarello M, Tacconelli E, Donati KG, Leone F, Morace G, Cauda R, Ortona L: Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 19: 490-497.CrossRefPubMed Tumbarello M, Tacconelli E, Donati KG, Leone F, Morace G, Cauda R, Ortona L: Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 19: 490-497.CrossRefPubMed
Metadata
Title
Bacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort study
Authors
Bekele Afessa
Ian Morales
Bethany Weaver
Publication date
01-12-2001
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2001
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-1-13

Other articles of this Issue 1/2001

BMC Infectious Diseases 1/2001 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine